Physician profile
Anselm Anyoha
NPI 1598788770
$1,041.24
in general payments reported to CMS, 2019-2025
7 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.23 · 2020: $60.77 · 2021: $77.50 · 2022: $164 · 2023: $323 · 2024: $218 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $544.39 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Alexion Pharmaceuticals, INC. | $125.00 | 2023 | |
| Cranial Technologies, INC | $97.12 | 2020-2025 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $96.03 | 2025 | Zoryve |
| Pfizer INC. | $63.52 | 2024 | |
| Phadia US INC. | $59.23 | 2022-2024 | Immunocap |
| Glaxosmithkline, LLC. | $55.95 | 2025 | Penmenvy, Bexsero, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anselm Anyoha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.